Product Description: (±)-CPSI-1306 is an orally available antagonist of macrophage migration inhibitory factor (MIF).
Applications: COVID-19-immunoregulation
Formula: C15H16F2N2O3
References: [1]Sanchez-Zamora Y, et al. Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. FASEB J. 2010 Jul;24(7):2583-90./[2]Nagarajan P, et al. MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma. Mol Cancer Res. 2014 Sep;12(9):1292-302.
CAS Number: 1309793-47-2
Molecular Weight: 310.30
Compound Purity: 98.90
Research Area: Metabolic Disease; Inflammation/Immunology